Evaluation of a live, attenuated respiratory syncytial virus vaccine in infants.
about
Vaccines for the common coldWheeze as an adverse event in pediatric vaccine and drug randomized controlled trials: A systematic reviewReplacement of the F and G proteins of respiratory syncytial virus (RSV) subgroup A with those of subgroup B generates chimeric live attenuated RSV subgroup B vaccine candidates.Inactivation of respiratory syncytial virus by zinc finger reactive compounds.A respiratory syncytial virus (RSV) vaccine based on parainfluenza virus 5 (PIV5).Active and passive immunisation against respiratory syncytial virus.Respiratory syncytial virus vaccinesRespiratory syncytial virus infection in owl monkeys: viral shedding, immunological response, and associated illness caused by wild-type virus and two temperature-sensitive mutants.Rational design of human metapneumovirus live attenuated vaccine candidates by inhibiting viral mRNA cap methyltransferaseHyperimmune globulins in prevention and treatment of respiratory syncytial virus infections.Prevention of respiratory syncytial virus infections.Feasibility of aerosol vaccination in humans.Vaccines for neonatal viral infections: towards a live respiratory syncytial virus vaccine:a study in risk.Increased genetic and phenotypic stability of a promising live-attenuated respiratory syncytial virus vaccine candidate by reverse geneticsAdministration of a highly attenuated, live respiratory syncytial virus vaccine to adults and children.Interferon production by human mononuclear leukocytes: differences between respiratory syncytial virus and influenza virusesRespiratory syncytial virus modified by deletions of the NS2 gene and amino acid S1313 of the L polymerase protein is a temperature-sensitive, live-attenuated vaccine candidate that is phenotypically stable at physiological temperature.Effectiveness of enteric immunization in the development of secretory immunoglobulin A response and the outcome of infection with respiratory syncytial virus.Live-attenuated respiratory syncytial virus vaccines.Pulmonary immunity and immunopathology: lessons from respiratory syncytial virus.Vaccines for the common cold.Efficacy and safety studies of a recombinant chimeric respiratory syncytial virus FG glycoprotein vaccine in cotton rats.Location of a highly conserved neutralizing epitope in the F glycoprotein of human respiratory syncytial virus.Pathogenesis of respiratory syncytial virus vaccine-augmented pathology.A viral-vectored RSV vaccine induces long-lived humoral immunity in cotton rats
P2860
Q24201977-1B0455C9-6C83-45E1-AFBC-0A1A4A02EB56Q26796334-95979431-F844-49F0-B826-CD34491590A9Q27469749-AAB159DF-ECDA-4FD4-BEDC-B62524FE7166Q33663190-325774DB-DBF9-4A0D-B78D-0D0F30D9FAA4Q33690612-B246E4BB-4E09-4884-8F94-0754C90F14E3Q33782438-3B4988E8-EAEB-4CD2-B813-3444E67B528AQ33975330-4E01F702-7C5E-40C2-BD11-F44F036B8699Q34100392-61AB08D3-D333-40B1-9C25-A2E41A220BF9Q34261898-10A64811-5998-4194-BBDF-27ED0424727EQ34307704-A7CB2D50-CB53-4B8E-BFDA-EE516714C31EQ34342190-A812EA57-94A1-4C06-B4A8-978B896F8048Q35091812-1FF8969B-FEB9-4DB0-9DF6-66499AA38391Q35843602-B9846B5A-17C2-4906-8A63-14B3D215F39BQ36276526-65582FEC-1294-4D3B-909E-7FAB74E87FC9Q36330347-3B7B1420-261A-411A-B500-E30903C841E0Q36422956-B03AE877-7BD0-4397-89A1-BA44B103C356Q36607430-BC4F11A2-08AD-45C9-A661-733D9A2369C0Q36679855-2A82A85D-6372-44B0-A4F7-D985B84D3C62Q36692801-26524E1B-387D-4595-B0E0-DDCB95EF9FC2Q37071608-A7586C29-31E3-4B4B-B8B6-AF729AAF32B2Q38682527-7AFFA8D2-5A77-4630-8651-5ED557A6BDDDQ39585262-3546B4C4-A446-421C-AB9C-CE24E702CAE1Q40107962-E654A666-D611-4D3C-B09E-4E15C45DE402Q40408366-31F8F50C-D86E-4CEB-B24F-11A2A7453DC1Q56794662-D230037A-9DBC-4E4B-BF6F-6DF8ADB88B3D
P2860
Evaluation of a live, attenuated respiratory syncytial virus vaccine in infants.
description
1976 nî lūn-bûn
@nan
1976年の論文
@ja
1976年学术文章
@wuu
1976年学术文章
@zh-cn
1976年学术文章
@zh-hans
1976年学术文章
@zh-my
1976年学术文章
@zh-sg
1976年學術文章
@yue
1976年學術文章
@zh
1976年學術文章
@zh-hant
name
Evaluation of a live, attenuated respiratory syncytial virus vaccine in infants.
@en
Evaluation of a live, attenuated respiratory syncytial virus vaccine in infants.
@nl
type
label
Evaluation of a live, attenuated respiratory syncytial virus vaccine in infants.
@en
Evaluation of a live, attenuated respiratory syncytial virus vaccine in infants.
@nl
prefLabel
Evaluation of a live, attenuated respiratory syncytial virus vaccine in infants.
@en
Evaluation of a live, attenuated respiratory syncytial virus vaccine in infants.
@nl
P2093
P1476
Evaluation of a live, attenuated respiratory syncytial virus vaccine in infants.
@en
P2093
P304
P356
10.1016/S0022-3476(76)81044-X
P407
P577
1976-06-01T00:00:00Z